Samsung in Talks to Buy Alzheimer's Drug Maker Biogen for $42 Billion: Report | Technology News
Samsung Bioepis seeks to buy Biogen biosimilar unit - KED Global
Biogen and Samsung land FDA approval for biosimilar to blockbuster Roche drug - MedCity News
Biogen Recoups Much-Needed $2.3B with Sale of Samsung Bioepis Stake | BioSpace
Biosimilaires : Biogen se déleste de Samsung Bioepis
Biogen to sell equity stake in Samsung Bioepis joint venture for up to $2.3B - Drug Discovery and Development
Biosimilaires : Samsung Bioepis conclut un nouvel accord de commercialisation avec Biogen | MyPharma Editions
Biogen and Samsung Bioepis present data for Infliximab and Adalimumab biosimilars - Hub Publishing
Biogen, Samsung Bioepis Enter New Biosimilars Transaction | Contract Pharma
Company News | Newsroom | SAMSUNG BIOLOGICS
Samsung Bioepis looks to acquire Biogen's biosim unit: reports
Biogen shares jump higher on report of potential Samsung acquisition
Samsung Bioepis : ventes record en Europe au T1 | AGENCE DE PRESSE YONHAP
Samsung Biologics Buys Bioepis Stake for $2.3 Billion From Biogen - Bloomberg
Biogen — Wikipédia
Samsung Bioepis conclut un nouvel accord de commercialisation avec Biogen
Samsung Bioepis ponders acquiring unit from U.S. partner Biogen
Logo De Société De Biotechnologie De Biogen Image éditorial - Image du médecines, hématologique: 102563960
Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture - PMLiVE
Is Samsung really 'at negotiating table' for Biogen? What we know so far - MM+M
Biogen Ups Investment in Biosimilar Drug Maker Samsung Bioepis by $700 Million | BioSpace
Samsung Group reportedly in talks to acquire Biogen < Pharma < Article - KBR
Samsung BioLogics says report on Biogen deal talks untrue | Fox Business
Samsung Biologics buys out Biogen in biosim venture for US$2.3B | HealthCare Middle East & Africa Magazine
